Stocks · Health care · Pharmaceutical Preparations

Immunome Inc.

IMNM Clue Score30
United States Fiscal year ends December CIK 0001472012 Results filed 11 Aug 2026

What the insiders did No buying or selling

By person

10 insiders · 0 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Clay B Siegall
President and CEO
—
—
—
870,704
$22.05M
+107.5%
Philip Wagenheim
Director
—
—
—
341,147
$8.64M
−16.0%
Max Rosett
Chief Financial Officer
—
—
—
101,287
$2.56M
+113.3%
Isaac Barchas
Director
—
—
—
92,211
$2.33M
−89.7%
Philip Tsai
Chief Technical Officer
—
—
—
81,550
$2.06M
—
Robert Lechleider
Chief Medical Officer
—
—
—
69,805
$1.77M
—
Jack Higgins
Chief Scientific Officer
—
—
—
60,250
$1.53M
+314.7%
Sandra G. Stoneman
Chief Legal Officer & GC
—
—
—
43,805
$1.11M
+688.6%
Jean Jacques Bienaime
Director
—
—
—
43,415
$1.10M
+161.3%
Kinney Horn
Chief Business Officer
—
—
—
0
$0.00
—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.